Trial ID
21552
Sponsor ID
RGX-104-001
“A Phase 1 Study of RGX-104, a Small Molecule LXR Agonist, as a Single Agent and as Combination Therapy in Patients with Advanced Solid Malignancies and Lymphoma with an Expansion in Select Malignancies (RGX-104-001)”
Principal Investigator
Alexander I. Spira, MD, PhD, FACPLocations
Fairfax Office
Learn More About This Trial
Other Relevant Trials
Trial ID
TOS-358-001
Sponsor ID
Totus
A Study to Evaluate the Safety and Tolerability of the Covalent Phosphoinositide-3-Kinase (PI3K)-alpha Inhibitor, TOS-358, in Adult Subjects with Select Solid Tumors
Principal Investigator
Alexander I. Spira, MD, PhD, FACP
1 Location
Trial ID
NP-G2-044-P2-01
Sponsor ID
Novita
NP-G2-044 as Monotherapy and Combination Therapy in Patients With Advanced or Metastatic Solid Tumor Malignancies
Principal Investigator
Alexander I. Spira, MD, PhD, FACP
1 Location
